Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BEAM, BOL, KERA, LASE, LCAV, LVCI, LZRC, VISX, SNRS, STAA -- Ignore unavailable to you. Want to Upgrade?

To: Gordon A. Langston who wrote (90)	5/11/1999 6:17:00 PM
From: Joe	Read Replies (2) \| Respond to of 253

Gordon, Looked for that one for some time a while back. Thanks. Joe

To: Gordon A. Langston who wrote (90)	5/12/1999 3:17:00 PM
From: HerbVic	Respond to of 253

Thanks Gordon! Thanks to you, I finally found the answer to my question at sum-tech.com 1989 - First photorefractive (PRK) patient 1990 - Summit conducts first International User's Congress, Zurich, Switzerland 1991 - First aspheric treatment 1992 - First astigmatism treatment 1993 - First hyperopia treatment 1995 - First FDA-approved PMA for PTK excimer laser system 1995 - First FDA-approved PMA for PRK excimer laser system 1997 - FDA approval of Apex Plus 1998 - FDA Approved for Astigmatism with emphasis® disc technology Definitions: • Photorefractive Keratectomy (PRK): The Apex Plus encompasses the leading technology in excimer laser surgery into an easy-to-use work station. Using a 6mm optical zone, the Apex Plus may treat mild to moderate myopia from 1.5 to 7.0 diopters in patients with low astigmatism ( In the U.S. clinical trials using a 6mm zone, myopia treatments with the Apex Plus produced uncorrected visual acuity results of 20/40 or better in 96% of patients. It is estimated that 90% of the 60 million Americans with myopia may be eligible for laser vision correction with a Summit Apex Plus laser. The Apex Plus may also treat corneal irregularities in Phototherapeutic Keratectomy procedures. • Phototherapeutic Keratectomy (PTK): Phototherapeutic Keratectomy is a minimally invasive treatment of corneal irregularities. PTK can be used to improve a patient's vision and/or comfort. The Apex Plus is approved for use in PTK procedures which treat superficial corneal pathology in patients with Superficial Corneal Dystrophies, Epithelial Basement Membrane Dystrophy, Irregular Corneal Surfaces, Corneal Scars and Opacities. Looks to me as though this is one great investment opportunity! One area of concern though is the consensus 5 year growth rate of 6%. What's the deal here? Granted the numbers are subject to change, especially in light of the recent merger, but SIX PERCENT? Can anyone shed light on this apparent contradiction? HerbVic